ARTICLE | Clinical News
Strathspey's Alphaeon subsidiary submits BLA to FDA for frown lines candidate
June 9, 2017 7:50 PM UTC
The Alphaeon Corp. subsidiary of Strathspey Crown Holdings LLC (Newport Beach, Calif.) said that its Evolus Inc. unit submitted a BLA to FDA for DWP-450 to treat adults with glabellar lines, also kno...
BCIQ Company Profiles